Agios Pharmaceuticals AGIO reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Agios Pharmaceuticals beat estimated earnings by 15.34%, reporting an EPS of $-1.49 versus an estimate of $-1.76.
Revenue was up $3.52 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.07 which was followed by a 3.95% increase in the share price the next day.
Here's a look at Agios Pharmaceuticals's past performance:
|Quarter||Q2 2022||Q1 2022||Q4 2021||Q3 2021|
To track all earnings releases for Agios Pharmaceuticals visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.